Catheter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Catheter Market is projected to expand from USD 59.02 Billion in 2025 to USD 83.77 Billion by 2031, reflecting a CAGR of 6.01%. Catheters are thin medical tubes utilized to inject, administer, or drain fluids from body cavities, ducts, or vessels during surgical and therapeutic interventions. Key drivers propelling this market include the rising prevalence of chronic conditions, such as urinary disorders and cardiovascular diseases, which demand minimally invasive treatments. Additionally, the aging global population is increasing the volume of surgical procedures that require these devices for effective patient care. As reported by the American Heart Association in 2024, cardiovascular disease was responsible for approximately one in three deaths worldwide, underscoring the sustained need for cardiac interventional tools.

However, market growth faces a significant hurdle due to the high rate of healthcare-associated infections, particularly those linked to urinary tract instrumentation. These complications frequently lead to extended hospitalizations and increased medical costs, compelling healthcare providers to enforce strict protocols. As a result, institutions may limit the routine or prolonged use of these devices to minimize risks, which subsequently restricts the overall utilization and expansion of the market.

Market Drivers

The growing preference for minimally invasive diagnostic and surgical techniques is a primary force driving the global catheter market, as healthcare providers increasingly favor methods that decrease patient trauma and recovery times. This shift has accelerated the development and consumption of specialized interventional tools, especially within structural heart therapies and cardiac electrophysiology. The demand for these advanced systems is reflected in the financial results of major industry players; for instance, Boston Scientific reported in October 2024 that its Electrophysiology business, driven by the FARAPULSE Pulsed Field Ablation system, saw a global net sales increase of 177.0% compared to the previous year. Similarly, Abbott’s Medical Devices segment recorded an 11.7% sales increase to $4.75 billion in the third quarter of 2024, supported by double-digit growth in catheter-intensive sectors.

concurrently, the integration of artificial intelligence and smart sensors into catheter designs is transforming the market by improving patient safety and clinical decision-making. Manufacturers are evolving beyond passive tubing to produce intelligent systems capable of delivering predictive analytics and real-time hemodynamic data, which are vital in critical care settings. This trend has triggered significant market consolidation and investment in advanced monitoring technologies. In September 2024, Becton, Dickinson and Company (BD) finalized the acquisition of Edwards Lifesciences' Critical Care unit for $4.2 billion to broaden its portfolio of AI-enabled clinical decision tools and smart connected care solutions, highlighting the industry's pivot toward high-tech, sensor-integrated devices.

Market Challenges

The widespread occurrence of healthcare-associated infections (HAIs), specifically catheter-associated urinary tract infections (CAUTIs), serves as a major restraint on the Global Catheter Market. This issue hampers growth by forcing healthcare facilities to implement rigorous "catheter-avoidance" strategies to control costs and minimize patient risk. Since hospitals often face financial penalties and non-reimbursement for hospital-acquired conditions, providers are adopting protocols that restrict the routine placement or mandate the early removal of indwelling catheters. This operational shift significantly lowers the frequency of device usage and the volume of replacements, thereby reducing the overall market demand for these consumables.

The persistence of these infections reinforces the need for such restrictive measures, limiting the addressable market size. Data from the European Centre for Disease Prevention and Control in 2024 indicates that urinary tract infections comprised 19.2% of all reported healthcare-associated infections in acute care hospitals. This statistic demonstrates that despite improvements in care, urinary instrumentation remains a leading cause of infectious complications. Consequently, the continued focus on reducing this rate compels healthcare systems to prioritize alternative management methods over catheterization, directly impeding the volume-driven growth of the market.

Market Trends

The rise of home-based patient care is accelerating the adoption of hydrophilic single-use intermittent catheters. Patients increasingly prefer these low-friction devices for self-catheterization because they lower the risk of urethral trauma and complications compared to long-term indwelling tubes. This shift toward independence and comfort is driving higher sales volumes for urology divisions focused on user experience. For example, Coloplast reported in its August 2024 interim financial report that its Continence Care business achieved 8% organic growth year-to-date, a performance largely attributed to the successful launch and adoption of the Luja intermittent catheter series.

Simultaneously, the advancement of next-generation balloon catheters equipped with intravascular lithotripsy is revolutionizing the treatment of complex calcified cardiovascular lesions. These sophisticated devices employ sonic pressure waves to fracture calcium within artery walls, providing a safer alternative to traditional high-pressure balloons that carry a risk of vessel dissection. Recognizing the high clinical value of this technology for treating coronary and peripheral artery disease, major corporations are investing heavily to secure these platforms. Notably, Johnson & Johnson completed the acquisition of Shockwave Medical in May 2024 for approximately $13.1 billion, aiming to extend its medtech leadership into vascular calcium modification and heart recovery.

Key Players Profiled in the Catheter Market

• Hollister Incorporated
• Medtronic PLC
• Boston Scientific Corporation
• Edward Lifesciences
• Smith Medical Inc.
• Teleflex Incorporated
• ConvaTec Group PLC
• Cure Medical LLC
• Terumo Corporation
• Cook Medical Inc.

Report Scope

In this report, the Global Catheter Market has been segmented into the following categories:

Catheter Market, by Product Type:

• Cardiovascular Catheters(Electrophysiology Catheters
• PTCA Balloon Catheters
• IVUS Catheters
• PTA Balloon Catheters)
• Urology Catheters (Hemodialysis Catheters
• Peritoneal Catheters
• Foley Catheters
• Intermittent Catheters
• External Catheters)
• Intravenous Catheters(Peripheral Catheters
• Midline Peripheral Catheters
• Central Venous Catheters)
• Neurovascular Catheters (Specialty Catheters
• Wound/Surgical Catheters
• Oximetry Catheters
• Thermodilution Catheters
• IUI Catheters)

Catheter Market, by End Use:

• Hospital Stores
• Retail Stores
• Others

Catheter Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Catheter Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.